U.S. markets closed
  • S&P Futures

    4,171.50
    -4.75 (-0.11%)
     
  • Dow Futures

    33,998.00
    -83.00 (-0.24%)
     
  • Nasdaq Futures

    14,049.25
    +19.75 (+0.14%)
     
  • Russell 2000 Futures

    2,253.40
    -5.60 (-0.25%)
     
  • Crude Oil

    62.94
    -0.19 (-0.30%)
     
  • Gold

    1,779.40
    -0.80 (-0.04%)
     
  • Silver

    25.91
    -0.20 (-0.77%)
     
  • EUR/USD

    1.1960
    -0.0020 (-0.17%)
     
  • 10-Yr Bond

    1.5730
    +0.0430 (+2.81%)
     
  • Vix

    16.25
    -0.32 (-1.93%)
     
  • GBP/USD

    1.3833
    -0.0007 (-0.05%)
     
  • USD/JPY

    108.6300
    -0.1530 (-0.14%)
     
  • BTC-USD

    56,905.89
    -3,009.10 (-5.02%)
     
  • CMC Crypto 200

    1,294.84
    -96.87 (-6.96%)
     
  • FTSE 100

    7,019.53
    +36.03 (+0.52%)
     
  • Nikkei 225

    29,748.10
    +64.73 (+0.22%)
     

AGCO Corp's (AGCO) Q4 Earnings & Sales Top Estimates, Up Y/Y

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
Zacks Equity Research
·5 min read
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

AGCO Corporation AGCO delivered fourth-quarter 2020 adjusted earnings per share of $1.54, up 39% year over year. The reported figure beat the Zacks Consensus Estimate of $1.08 per share. The company’s quarterly results reflect sales growth and margin expansion across all segments.

Revenues increased 7.5% year over year to $2,717 million during the December-end quarter. The top-line figure also beat the Zacks Consensus Estimate of $2,493 million. Excluding the favorable currency-translation impact of 1.4%, net sales were up 6.7% year over year.

Operational Update

Cost of sales grew 6.1% year over year to $2,122 million in the fourth quarter. Gross profit was up 13.7% year over year to $596 million during the reported quarter. Gross margin came in at 22% compared with the prior-year period’s 20%.

Selling, general and administrative expenses flared up to $283 million from the year-ago quarter’s $272 million. Adjusted income from operations surged 44.3% year over year to $192 million. Consequently, operating margin came in at 7% compared with the year-earlier quarter’s 5%.

AGCO Corporation Price, Consensus and EPS Surprise

AGCO Corporation Price, Consensus and EPS Surprise
AGCO Corporation Price, Consensus and EPS Surprise

AGCO Corporation price-consensus-eps-surprise-chart | AGCO Corporation Quote

Segment Performance

Sales in the North America segment were down 10.2% year over year to $485 million during the October-December period. The segment reported an operating income of $9.8 million compared with the prior-year quarter’s $7.1 million.

Sales in the South America segment climbed 21.1% year over year to $268 million. The segment reported an operating profit of $16 million, as against the prior-year quarter’s operating loss of $18.2 million.

The EME (Europe/Middle East) segment’s sales came in at $1,723 million compared with the $1,515 million recorded in the year-ago period. The EME’s operating income was up 12.3% year over year to $205 million.

Sales in the Asia/Pacific segment were up 2.1% year on year to $242 million. The segment reported an operating profit of $26 million compared with the year-ago quarter’s $22 million.

Financial Update

AGCO reported cash and cash equivalents of $1,119 million as of Dec 31, 2020, up from the $433 million recorded as of Dec 31, 2019. The company generated $897 million of cash from operating activities in 2020 compared with the $696 million recorded in 2019.

2020 Results

AGCO reported adjusted earnings per share of $5.61 in 2020, up 26.3% from the prior-year reported figure of $4.44. Earnings also beat the Zacks Consensus Estimate of $5.14.

Sales were up 1.2% year over year to $9.15 billion from the prior-year figure of $9.04 billion. The top line also surpassed the Zacks Consensus Estimate of $8.93 billion.

Guidance

The company expects net sales for the ongoing year to lie between $10.2 billion and $10.4 billion, suggesting improved sales volumes, pricing and positive impacts of foreign-currency translation. Gross and operating margins are projected to be higher than 2020 levels, reflecting higher sales and production volumes as well as margin-improvement plans. These improvements will support AGCO’s investments in precision agriculture and digital initiatives. Considering these, AGCO expects adjusted earnings per share for the current year in the range of $7.00 to $7.25.

Higher commodity prices and improved farmer sentiment are anticipated to drive North American industry sales in the current year. Healthy crop production and favorable exchange rates in Brazil and Argentina are supporting positive economics in South America, while strong replacement demand will result in higher industry sales compared with 2020. Increasing demand for commodities, driven by the growing world population, rising emerging market protein consumption and biofuel use, will likely strengthen prospects of the agricultural industry.

Share Price Performance

Over the past year, AGCO’s stock has gained 75.3%, outperforming the industry’s growth of 75.2%.



Zacks Rank and Other Stocks to Consider

AGCO currently sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Some other top-ranked stocks in the industrial products sector are Apogee Enterprises, Inc. APOG, AptarGroup Inc. ATR and Crown Holdings, Inc. CCK, each carrying a Zacks Rank #2 (Buy) at present.

Apogee has an expected earnings growth rate of 1.26% for the current fiscal year. The company’s shares have gained around 10.7% in the past year.

AptarGroup has a projected earnings growth rate of 14.4% for the current fiscal year. The stock has appreciated around 17% in a year’s time.

Crown Holdings has an estimated earnings growth rate of 11.7% for the current fiscal year. The company’s shares have rallied nearly 21% over the past year.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Apogee Enterprises, Inc. (APOG) : Free Stock Analysis Report

Crown Holdings, Inc. (CCK) : Free Stock Analysis Report

AptarGroup, Inc. (ATR) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research